Belpointe Asset Management LLC Raises Holdings in HCA Healthcare, Inc. $HCA

Belpointe Asset Management LLC grew its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 5.7% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 2,347 shares of the company’s stock after purchasing an additional 126 shares during the quarter. Belpointe Asset Management LLC’s holdings in HCA Healthcare were worth $899,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in shares of HCA Healthcare by 11.9% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 25,454 shares of the company’s stock worth $8,796,000 after buying an additional 2,698 shares during the last quarter. Park Place Capital Corp grew its holdings in shares of HCA Healthcare by 2,336.0% during the second quarter. Park Place Capital Corp now owns 1,218 shares of the company’s stock worth $474,000 after buying an additional 1,168 shares during the last quarter. Harrell Investment Partners LLC grew its holdings in shares of HCA Healthcare by 176.3% during the second quarter. Harrell Investment Partners LLC now owns 1,815 shares of the company’s stock worth $695,000 after buying an additional 1,158 shares during the last quarter. Brown Advisory Inc. boosted its holdings in HCA Healthcare by 53.9% in the 1st quarter. Brown Advisory Inc. now owns 4,630 shares of the company’s stock valued at $1,600,000 after purchasing an additional 1,622 shares in the last quarter. Finally, Farther Finance Advisors LLC boosted its holdings in HCA Healthcare by 26.9% in the 1st quarter. Farther Finance Advisors LLC now owns 1,141 shares of the company’s stock valued at $395,000 after purchasing an additional 242 shares in the last quarter. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on HCA shares. JPMorgan Chase & Co. lifted their price objective on HCA Healthcare from $360.00 to $370.00 and gave the company a “neutral” rating in a report on Monday, August 4th. Robert W. Baird lifted their price objective on HCA Healthcare from $380.00 to $423.00 and gave the company a “neutral” rating in a report on Thursday, August 14th. Barclays lifted their price objective on HCA Healthcare from $390.00 to $445.00 and gave the company an “overweight” rating in a report on Thursday, September 18th. Truist Financial lifted their price target on shares of HCA Healthcare from $390.00 to $415.00 and gave the company a “buy” rating in a research report on Wednesday, July 16th. Finally, Cantor Fitzgerald reiterated an “overweight” rating and set a $444.00 price target on shares of HCA Healthcare in a research report on Tuesday. One investment analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and nine have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $422.31.

HCA Healthcare Price Performance

Shares of HCA Healthcare stock opened at $426.09 on Thursday. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $439.01. The company has a market capitalization of $99.70 billion, a P/E ratio of 17.91, a P/E/G ratio of 1.38 and a beta of 1.40. The business has a 50 day moving average price of $402.68 and a 200 day moving average price of $374.46.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings data on Friday, July 25th. The company reported $6.84 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.20 by $0.64. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.The firm had revenue of $18.61 billion during the quarter, compared to the consensus estimate of $18.49 billion. During the same period in the previous year, the firm posted $5.50 EPS. The company’s quarterly revenue was up 6.4% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. As a group, research analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 30th. Shareholders of record on Tuesday, September 16th were paid a $0.72 dividend. This represents a $2.88 annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend was Tuesday, September 16th. HCA Healthcare’s payout ratio is presently 12.11%.

Insider Buying and Selling

In other HCA Healthcare news, EVP Michael S. Cuffe sold 3,836 shares of HCA Healthcare stock in a transaction that occurred on Monday, September 8th. The shares were sold at an average price of $418.84, for a total value of $1,606,670.24. Following the completion of the sale, the executive vice president directly owned 31,503 shares of the company’s stock, valued at approximately $13,194,716.52. The trade was a 10.85% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 1.30% of the company’s stock.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.